Canada Life
XENT

Canada Life’s Intersect ENT, Inc XENT Stock Holding History

Canada Life’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,341
Closed -$40K – 2497
2022
Q1 		$40K Sell
1,341
-779
-37% -$21.3K ﹤0.01% 2216
2021
Q4 		$58K Hold
2,120
– – ﹤0.01% 2139
2021
Q3 		$58K Hold
2,120
– – ﹤0.01% 2195
2021
Q2 		$36K Hold
2,120
– – ﹤0.01% 2359
2021
Q1 		$44K Hold
2,120
– – ﹤0.01% 2332
2020
Q4 		$48K Hold
2,120
– – ﹤0.01% 2295
2020
Q3 		$35K Hold
2,120
– – ﹤0.01% 2281
2020
Q2 		$28K Hold
2,120
– – ﹤0.01% 2424
2020
Q1 		$25K Hold
2,120
– – ﹤0.01% 2336
2019
Q4 		$52K Buy
+2,120
New +$43K ﹤0.01% 2252
2019
Q3 		– Sell
-3,995
Closed -$91K – 2528
2019
Q2 		$91K Hold
3,995
– – ﹤0.01% 2261
2019
Q1 		$128K Hold
3,995
– – ﹤0.01% 1990
2018
Q4 		$109K Hold
3,995
– – ﹤0.01% 2118
2018
Q3 		$115K Hold
3,995
– – ﹤0.01% 2150
2018
Q2 		$149K Hold
3,995
– – ﹤0.01% 2065
2018
Q1 		$157K Hold
3,995
– – ﹤0.01% 2027
2017
Q4 		$129K Hold
3,995
– – ﹤0.01% 2101
2017
Q3 		$116K Buy
+3,995
New +$118K ﹤0.01% 2109

Canada Life's XENT Position: Q2 2022 in Review

Canada Life sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 1,341 shares — an estimated $40K sold.

Canada Life first reported a position in XENT in Q3 2017 and held it in 18 quarters. The position peaked at $157K in Q1 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Canada Life reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Canada Life sold 1,341 Intersect ENT, Inc shares in Q2 2022, an estimated $40K.
  • Canada Life first reported a position in Intersect ENT, Inc in Q3 2017 and held it in 18 quarters.
  • Canada Life's Intersect ENT, Inc position peaked at $157K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Canada Life's 13F filing for Q2 2022, filed 9 Aug 2022.